Home » Newsletters » BioWorld Science

BioWorld Science

June 28, 2007

View Archived Issues

Tego and NCI collaborate on development of fullerene formulation

Gilead reports promising phase III results for chronic hepatitis B

CytRx identifies arimoclomol dose for phase IIb trial

Positive phase I findings for topical antibiotic REP-8839

OBE-101 phase II obesity trial completes treatment

Beta-secretase inhibitor CTS-21166 begins initial phase I study

New trials commence for Heplisav

Roche completes acquisition of BioVeris

Ketasyn advances for the treatment of Alzheimer's disease

Enrollment opens for phase IIa study of KP-1461 in HIV

Intradigm selects Agilent for siRNA manufacturing

Positive results for deCODE's drug candidate DG-041 for arterial thrombosis

Molecular Insight initiates phase II pivotal registration trial for Zemiva

UCB and Biogen Idec's initiate phase II study of CDP-323 for MS

Novel SGLT inhibitors reduce postprandrial hyperglycemia in diabetic rats

DPP-IV inhibition with S-40010 enhances pancreatic beta-cell mass and reduces postprandrial glycemia

PSN-119-1: A GPR119 receptor agonist with antidiabetic and antiobesity properties

Positive results with novel selective PPARalpha agonist in diabetic monkeys

Potential targets for the treatment of sleep disorders

Amgen's new TRPV1 antagonist shows analgesic efficacy in rat pain models

Novel agents for HIV infection reported in recent Bristol-Myers Squibb patent

Novel analgesic agents imparted in recent Novartis and Novartis Pharma patents

Priority review granted for Isentress

New therapeutic agents for neurological disorders reported in recent patents

Rotarix filed for U.S. approval

Supplemental NDA filed for Nexavar in hepatocellular carcinoma

Tasigna submitted in Japan

Actos filed for use in combination with insulin in Japan

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...